Rebalix
UBS · sheet of 5 September 2026
UBS · sheet of 5 September 2026ETF sheet · official issuer and register data
UBS MSCI ACWI SF UCITS ETF USD Ukdis
IE00BJXFZ989 · IE00BJXFZ989 · USD · domicile Ireland
EquitySFDR art. 6
Index tracked: MSCI ACWI Total Return Net Index
- TER
- 0.21%+ trans. 0.00%
- Fund size
- —
- Tracking difference
- +0.04%3-year avg
- 🇮🇹 tax rate
- —white list not published
- Replication
- Synthetic (swap)
- Income
- Distributingsemi-annual
Launch 15 Apr 2019 · costs from the KID as of 26 Aug 2026 · 2 venues (ESMA register)
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 2 Sept 2026
The objective of the Fund is capital appreciation. The Fund tracks the daily performance of an equity index, called the MSCI ACWI Net Total Return Index (the 'Index'), less fees and costs and consequently is passively managed. The Fund invests in financial derivative instruments ('FDIs') with UBS AG, London Branch ('UBS') as counterparty. The Fund may also invest in securities (e.g. company shares and bonds issued by companies and governments). Under the terms of the FDIs, the performance of the Index is swapped from UBS to the Fund, and in return the…
Performance since series start (in euro) — base 100
24 Nov 2021 → 3 Sept 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
Returns in euro
| 1 year | +24.1% |
| 3 years | +63.9% |
| 5 years | series too young |
| 10 years | series too young |
| Since series start | +60.3% |
Risk · 1 / 3 / 5 years
| Volatility (ann.) | 11.44% | 12.22% | — |
| Max drawdown | −9.29% | −16.07% | — |
| Sharpe | 1.55 | 1.16 | — |
| Sortino | 2.31 | 1.65 | — |
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · IE00BJXFZ989 · IE00BJXFZ9891
RebalixIE00BJXFZ989 · IE00BJXFZ989 · sheet of 5 September 2026
Tracking difference — year by year
Fund minus index, complete calendar years · fund with dividends reinvested by Rebalix on each ex-date (no issuer total-return series); index from the declared series
| Year | Fund | Index | TD |
|---|---|---|---|
| 2025 | +22.35% | +22.34% | +0.01% |
| 2024 | +17.58% | +17.49% | +0.09% |
| 2023 | +22.23% | +22.20% | +0.03% |
Distributions · per share, in USD
Frequency: semi-annual · last 12 months: 2.9193 USD (1.36% of NAV) · last ex-date 13 Aug 2026
| Year | Payments | Total (USD) | Dividend yield |
|---|---|---|---|
| 2026 | 2 | 2.9193 | — |
| 2025 | 2 | 3.0823 | +1.95% |
| 2024 | 2 | 3.4186 | +2.48% |
| 2023 | 2 | 2.6491 | +2.30% |
| 2022 | 2 | 2.4727 | +1.72% |
Dividend yield: the year’s distributions over the share value (NAV) at the start of the year.
Listing venues
ESMA register (FIRDS) and official exchange lists
NY80 · Börse Hannover, Tradegate Exchange
+ 2 unmapped venues (MTF, RFQ, professional)
Official documents
Clickable links in the PDF
The live sheet, always up to date
rebalix.com/en/etf/IE00BJXFZ989
Series, distributions, holdings and documents refresh daily.
rebalix.com/en/etf/IE00BJXFZ989
Series, distributions, holdings and documents refresh daily.
Sheet produced on 5 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.
Rebalix · IE00BJXFZ989 · IE00BJXFZ9892